![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/4365 | |
A61K 31/44 | |||
A61K 45/06 | |||
A61P 7/02 | |||
A61P 9/10 |
(11) | Number of the document | 2155195 |
(13) | Kind of document | T |
(96) | European patent application number | 08742820.7 |
Date of filing the European patent application | 2008-04-11 | |
(97) | Date of publication of the European application | 2010-02-24 |
(45) | Date of publication and mention of the grant of the patent | 2014-07-16 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2008/004760 |
Date | 2008-04-11 |
(87) | Number | WO 2008/127682 |
Date | 2008-10-23 |
(30) | Number | Date | Country code |
911852 P | 2007-04-13 | US |
(72) |
SINHA, Uma, US
HOLLENBACH, Stanley, J., US
ANDRE, Patrick, US
|
(73) |
Millennium Pharmaceuticals, Inc.,
40 Landsdowne Street, Cambridge, MA 02139,
US
|
(54) | Combination anticoagulant therapy with a compound that acts as a factor Xa inhibitor |
Combination anticoagulant therapy with a compound that acts as a factor Xa inhibitor |